As of May 24, 2025, CorVel Corp (CRVL) reports a Gross Margin of 21.59%.
Gross Margin indicates the portion of sales revenue remaining after covering production costs, highlighting operational efficiency.
Historical Trend of CorVel Corp's Gross Margin
Over recent years, CorVel Corp's Gross Margin has shown a stable trend. The table below summarizes the historical values:
| Date | Gross Margin |
|---|---|
| 2024-03-31 | 21.59% |
| 2023-03-31 | 22.02% |
| 2022-03-31 | 23.54% |
| 2021-03-31 | 22.37% |
| 2020-03-31 | 21.26% |
This slight upward trend highlights how CorVel Corp manages its operational efficiency and pricing power over time.
Comparing CorVel Corp's Gross Margin to Peers
To better understand CorVel Corp's position, it's useful to compare its Gross Margin against industry peers. Below are selected comparisons:
| Company | Gross Margin |
|---|---|
| CorVel Corp (CRVL) | 21.59% |
| Lifestance Health Group Inc (LFST) | 7775.20% |
| First Choice Healthcare Solutions Inc (FCHS) | 100.00% |
| Global Cord Blood Corp (CO) | 85.26% |
| Biodesix Inc (BDSX) | 78.17% |
| Cryo-Cell International Inc (CCEL) | 75.15% |
Compared to its competitors, CorVel Corp's Gross Margin is about average compared to peers, indicating industry-standard operational efficiency.